NEW YORK, July 22, 2026 – Zhongchao Inc. (NASDAQ: ZCMD) experienced an extraordinary trading session on Wednesday, with shares skyrocketing 456% to $8.18 by 11:02 a.m. EDT. The dramatic price movement occurred during regular Nasdaq trading hours, catching the attention of market participants.
Unprecedented Volume
Trading volume for ZCMD reached a staggering 65.79 million shares by 10:53 a.m., which represents approximately 57 times the company's public float of 1.15 million shares. This level of turnover is highly unusual and suggests that market structure, rather than any fundamental news, was the primary driver behind the spike.
The company's last press release was dated June 25, indicating that no fresh operating data or corporate announcements fueled the surge. Instead, the rally appears to be a classic low-float phenomenon, where limited available shares can lead to extreme price volatility when demand surges.
Multiple Trading Halts
The stock was subject to three Limit Up-Limit Down (LULD) pauses before 10:30 a.m., as the rapid price increase triggered circuit breakers designed to prevent excessive volatility. Meanwhile, the broader Nasdaq Composite index was down 0.32% at the same time, highlighting that Zhongchao's move was company-specific.
Short Interest and Float Dynamics
Short positioning may have contributed to the rally. According to MarketWatch, as of June 30, there were 378,500 shares short, representing 32.95% of the float. While this does not definitively prove that short covering drove Wednesday's move, such a high short interest relative to the float can create conditions for a short squeeze.
The public float has been significantly compressed by three reverse stock splits this year: 1-for-8 on March 2, 1-for-31 on June 8, and 1-for-3 on June 29. For shareholders who held throughout, the cumulative effect is a 1-for-744 consolidation. Zhongchao stated that the final reverse split was intended to maintain its Nasdaq listing, leaving approximately 1.15 million Class A shares outstanding.
Capital Raise and Dilution Risk
The shrinking float followed a May capital raise, in which Zhongchao priced 9.26 million units at 54 cents, targeting $5 million in gross proceeds. Each unit consisted of either a share or a pre-funded warrant, plus a six-month warrant. These warrants pose a significant supply risk, as the prospectus indicates that one warrant could yield up to nine shares at the stated floor. Zero-price exercises would bring no cash to the company and cause substantial dilution.
Financial Performance
Zhongchao's operating results provide little fundamental support for the recent price surge. Audited 2025 revenue fell 28% to $11.37 million, while the consolidated net loss widened to $5.81 million from $0.27 million. Cash on hand at year-end was $8.10 million. The company, a Cayman Islands holding entity, operates in the oncology and major-disease patient services sector through contractual VIE arrangements, and it notes that it owns no equity in the VIE or its subsidiaries.
Risks and Outlook
Low-float rallies can reverse sharply, and the potential for warrant exercises to expand the share supply remains a key risk. Renewed listing pressure could trigger further corporate actions. Additionally, the VIE structure introduces regulatory and enforcement uncertainties.
For investors, the next critical data points will be the company's next filing, which should disclose share count, warrant exercises, and cash usage. These fundamentals will matter far more than Wednesday's dramatic tape action.
